Type 1 Diabetes Trial, Recruiting NCT07676565 Sponsor: Indiana University Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT07676565
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who have been clinically diagnosed with Type 1 Diabetes
  • People who have been prescribed one of two types of diabetes-related medications — either a GLP-1 receptor agonist or an SGLT inhibitor (SGLT-1 or SGLT-2) — by their doctor for any reason as part of their normal care, and who have been taking it for no more than one week
  • People who use a continuous glucose monitor (a small device that tracks blood sugar levels throughout the day) and have at least one month of data from it available before joining, with that data expected to continue being available for the whole study
  • People who are willing and able to give their informed consent to participate

Who may not be able to join:

  • Anyone who does not meet all of the inclusion criteria listed above

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (317)-278-2752

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
24 March 2026
Est. completion
1 April 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in HbA1c by type of therapy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov